EP1135141A4 - Phospholipase inhibitors for the treatment of cancer - Google Patents

Phospholipase inhibitors for the treatment of cancer

Info

Publication number
EP1135141A4
EP1135141A4 EP99957727A EP99957727A EP1135141A4 EP 1135141 A4 EP1135141 A4 EP 1135141A4 EP 99957727 A EP99957727 A EP 99957727A EP 99957727 A EP99957727 A EP 99957727A EP 1135141 A4 EP1135141 A4 EP 1135141A4
Authority
EP
European Patent Office
Prior art keywords
cancer
treatment
phospholipase inhibitors
phospholipase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99957727A
Other languages
German (de)
French (fr)
Other versions
EP1135141A1 (en
Inventor
Albert Peng Sheng Tseng
Kevin William Broady
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Analytica Ltd
Original Assignee
Analytica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Analytica Ltd filed Critical Analytica Ltd
Publication of EP1135141A1 publication Critical patent/EP1135141A1/en
Publication of EP1135141A4 publication Critical patent/EP1135141A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP99957727A 1998-11-12 1999-11-12 Phospholipase inhibitors for the treatment of cancer Withdrawn EP1135141A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10825498P 1998-11-12 1998-11-12
US108254P 1998-11-12
PCT/AU1999/001004 WO2000028997A1 (en) 1998-11-12 1999-11-12 Phospholipase inhibitors for the treatment of cancer

Publications (2)

Publication Number Publication Date
EP1135141A1 EP1135141A1 (en) 2001-09-26
EP1135141A4 true EP1135141A4 (en) 2003-03-05

Family

ID=22321128

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99957727A Withdrawn EP1135141A4 (en) 1998-11-12 1999-11-12 Phospholipase inhibitors for the treatment of cancer

Country Status (3)

Country Link
EP (1) EP1135141A4 (en)
AU (1) AU1534900A (en)
WO (1) WO2000028997A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2294003T3 (en) * 2000-06-29 2008-04-01 Anthera Pharmaceuticals, Inc. REMEDIES AGAINST CANCER.
WO2018049014A1 (en) 2016-09-07 2018-03-15 Trustees Of Tufts College Dash inhibitors, and uses related thereto
US11559537B2 (en) 2017-04-07 2023-01-24 Trustees Of Tufts College Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonists

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0383947A (en) * 1989-08-29 1991-04-09 Yamanouchi Pharmaceut Co Ltd Novel q-5486-a substance and its production
WO1993001215A1 (en) * 1991-07-04 1993-01-21 Garvan Institute Of Medical Research Pla2 inhibitory compounds
WO1999029726A1 (en) * 1997-12-05 1999-06-17 Hsc (Pla) Pty. Ltd. Phospholipase inhibitor

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3345415B2 (en) * 1989-06-26 2002-11-18 ジェムスター ディベロプメント コーポレイション Method and apparatus for using coded video recording / playback timer reservation information
WO1997035588A1 (en) * 1996-03-27 1997-10-02 Uab Research Foundation Novel uses of phospholipase c inhibitors
US5663059A (en) * 1996-05-10 1997-09-02 Incyte Pharmaceuticals, Inc. Human phospholipase inhibitor
PT1019068E (en) * 1996-09-11 2009-10-08 Elizabeth Shanahan-Prendergast Therapeutic formulations containing snake and/or insect venom for the prophylaxis and therapy of neoplasms

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0383947A (en) * 1989-08-29 1991-04-09 Yamanouchi Pharmaceut Co Ltd Novel q-5486-a substance and its production
WO1993001215A1 (en) * 1991-07-04 1993-01-21 Garvan Institute Of Medical Research Pla2 inhibitory compounds
WO1999029726A1 (en) * 1997-12-05 1999-06-17 Hsc (Pla) Pty. Ltd. Phospholipase inhibitor

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199120, Derwent World Patents Index; Class B05, AN 1991-146158, XP002226285 *
FORTES-DIAS C L ET AL: "A PHOSPHOLIPASE A2 INHIBITOR FROM THE PLASMA OF THE SOUTH AMERICAN RATTLESNAKE (CROTALUS DURISSUS TERRIFICUS)", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOGICAL CHEMISTS, BALTIMORE, MD, US, vol. 269, no. 22, 3 June 1994 (1994-06-03), pages 15646 - 15651, XP002045502, ISSN: 0021-9258 *
See also references of WO0028997A1 *

Also Published As

Publication number Publication date
WO2000028997A1 (en) 2000-05-25
EP1135141A1 (en) 2001-09-26
AU1534900A (en) 2000-06-05

Similar Documents

Publication Publication Date Title
IL137540A0 (en) Inhibitors of phospholipase a2
ZA977087B (en) Methods of cancer treatment using naaladase inhibitors
AU2212299A (en) Compositions and methods for the treatment of tumor
GB9824436D0 (en) Methods of treatment
IL159461A0 (en) Method for enhancing the effectiveness of cancer therapies
SI1176964T1 (en) Uses of et743 for treating cancer
GB9821217D0 (en) Treatment for substrates
AU2001266838A1 (en) Inhibitors of matriptase for the treatment of cancer
IL127605A0 (en) Methods of cancer treatment using naaladase inhibitors
AU2001290165A8 (en) Components of canola for the treatment of cancer
AU8322401A (en) Indole compounds useful for the treatment of cancer
IL141426A0 (en) Compositions and methods for the treatment of tumor
GB2389532B (en) The method of treating cancer
HUP0101947A3 (en) Combination for the treatment of tumors
IL143212A0 (en) Compositions and methods for the treatment of tumor
EP1135141A4 (en) Phospholipase inhibitors for the treatment of cancer
GB9819999D0 (en) Treatment of cancer
AU1940800A (en) Combination therapy for the treatment of sepsis
GB2332849B (en) Apparatus for the treatment of soil
IL149281A0 (en) Treatment of cancer
AU2000263936A1 (en) Substance p analogs for the treatment of cancer
GB9804361D0 (en) Cancer treatment
GB9903035D0 (en) Treating cancer
SI1133290T1 (en) Use of inhibitors of acetylcholinesterase for the treatment of deliriums
IL124500A0 (en) Emulsions for cancer treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20010612

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7A 61P 35/00 B

Ipc: 7A 61K 38/00 A

A4 Supplementary search report drawn up and despatched

Effective date: 20030117

17Q First examination report despatched

Effective date: 20030731

RBV Designated contracting states (corrected)

Designated state(s): DE FR GB IT

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040211